The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
- 1 January 1987
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 65 (1), 23-29
- https://doi.org/10.1111/j.1365-2141.1987.tb06130.x
Abstract
The prognostic value of biological, clinical and laboratory features was analysed in a series of 265 patients with chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL). On univariate analysis seven features were shown to influence significantly the survival of the whole group of patients: absolute prolymphocyte count (ABS PROL), percentage of prolymphocytes (%PROL), WBC, spleen size, age, intensity of surface-membrane immunoglobulin (SmIg) and mouse (M) rosettes. Multivariate regression analysis of these features showed that only ABS PROL and spleen size had independent prognostic significance. The survival in PLL (38 cases) was significantly shorter than in CLL (227 cases) (median survival = 3 and 8 years, respectively). Patients with CLL with an increased %PROL (11-55%), defined as CLL/PL, could be divided into two groups: those with ABS PROL less than or equal to 15 X 10(9)/l (26 cases) fell within the 'standard-prognostic risk' for typical CLL (i.e. less than or equal to 10% PROL), whereas the survival outlook for the cases with ABS PROL greater than 15 X 10(9)/l (40 cases) was as bad as for PLL. A scoring system was generated with the four features that showed high prognostic significance: ABS PROL, spleen size, SmIg and M-rosettes. The score proved to be superior to any single feature as a predictor of survival, being especially useful in the analysis of the CLL/PL group: cases with high scores (greater than 2) had a median survival of 2.5 years, while the median has not been reached for those with low scores (less than or equal to 2). We suggest that this scoring system may help to identify the cases of CLL/PL that behave as PLL, and as such may benefit from different treatment.Keywords
This publication has 21 references indexed in Scilit:
- ‘Prolymphocytoid’ Cells in Chronic Lymphocytic Leukaemia and their Prognostic SignificanceScandinavian Journal of Haematology, 2009
- The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia.British Journal of Haematology, 1986
- Reactivity of the monoclonal antibody RFB1 in chronic B‐cell leukaemiasScandinavian Journal of Haematology, 1984
- Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging SystemBritish Journal of Haematology, 1981
- Identification of a Pure Splenic Form of Chronic Lymphocytic LeukaemiaBritish Journal of Haematology, 1979
- ‘Prolymphocytoid’ Transformation of Chronic Lymphocytic LeukaemiaBritish Journal of Haematology, 1979
- Guidelines for protocol studies in chronic lymphocytic leukemiaAmerican Journal of Hematology, 1978
- A clinical staging system for chronic lymphocytic leukemia.Prognostic significanceCancer, 1977
- Factors influencing the duration of survival of patients with chronic lymphocytic leukemiaAmerican Journal Of Medicine, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958